2014
DOI: 10.1007/978-1-62703-977-2_30
|View full text |Cite
|
Sign up to set email alerts
|

Measuring Binding Constants of His-Tagged Proteins Using Affinity Chromatography and Ni-NTA-Immobilized Enzymes

Abstract: Affinity chromatography is one way to measure the binding constants of a protein-ligand interaction. Here we describe a method of measuring a binding constant using Ni-NTA resin to immobilize a His-tagged enzyme and the method of frontal analysis. While other methods of immobilization are possible, using the strong affinity interaction between His-tagged proteins and Ni-NTA supports results in a fast, easy, and gentle method of immobilization. Once the affinity support is created, frontal analysis can be used … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Another notable technology in the analysis of drug-protein interactions is high performance affinity chromatography (HPAC) [19][20][21]. In HPAC, a protein is often immobilised on a solid matrix to construct an affinity stationary phase.…”
Section: Introductionmentioning
confidence: 99%
“…Another notable technology in the analysis of drug-protein interactions is high performance affinity chromatography (HPAC) [19][20][21]. In HPAC, a protein is often immobilised on a solid matrix to construct an affinity stationary phase.…”
Section: Introductionmentioning
confidence: 99%
“…To purify the protein of interest, about 300 mL of the fermentation supernatant after 144 h of methanol induction was centrifuged at 8000 × g for 5 min to remove the cells. The supernatants were collected and dialyzed against buffer A (20 mMTris-HCl; 5 mM Na 2 EDTA; pH 6.8) using a Millipore 10 kDa cut off membrane device at 4°C to remove ions and salts and then shake with Ni-NTA resin at 4°C for 3 h. After two washes with low concentrations of 25 mM imidazole, the protein was eluted with cell lysis buffer containing 10% glycerol and 300 mM imidazole to remove other proteins and small peptides as described in the Ni-NTA Resin Handbook by TransGen Biotechnology (China) (Etemadzadeh et al, 2015;Moser et al, 2014). The final, relatively pure sample was concentrated and stored in 15 mL biotin ligase storage buffer (50 mM imidazole, 50 mMNaCl, 5% glycerol, 5 mMTris-HCl, pH 6.8).…”
Section: Purification Of the Recombinant Fusion Biramentioning
confidence: 99%
“…To circumvent the difficulties of confirming the activity, a sf-GFP-fused streptavidin was expressed and surface displayed on the outer membrane of E. coli strain BL21 (DE3). The streptavidin is a tetrameric molecule that have an extremely high affinity for biotin with biotin binding sites at each subunit (Moser et al, 2014;Schmitz, 2002;Sau-Ching and Sui-Lam, 2005). Sf-GFP-fused-streptavidin displayed on the cell surface can detect biotinylated protein avi-tagged mcherry.…”
Section: Enzyme Activity Assaymentioning
confidence: 99%
“…This makes a powerful tool for characterizing drug–protein interactions. It is remarkable that high‐performance affinity chromatography (HPAC) (Anguizola et al, ; Moser, White, & Kovacs, ; Schiel, Ohnmacht, & Hage, ) possessing new mathematical tools is relatively rapid for obtaining information on drug–protein interactions. Among the reported mathematical models, frontal analysis (Kamarei, Gritti, Guiochon, & Burchell, ; Ràfols, Zarza, & Bosch, ), zonal elution (Matsuda, Li, Zheng, & Hage, ) and nonlinear chromatography (Li et al, ) are mostly utilized to determine the binding parameters of drug–protein interactions.…”
Section: Introductionmentioning
confidence: 99%